A study based on the proteomic profiling of plasma exosomes from lung cancer patients with metastasis suggested that MUC5B could serve as a potential biomarker for diagnosing lung cancer brain metastasis [20]. The gene discussed is MUC5B; the disease is lung carcinoma.